Trials / Unknown
UnknownNCT05572099
ExoDx Prostate Evaluation in Active Surveillance Patient Population
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (estimated)
- Sponsor
- Exosome Diagnostics, Inc. · Industry
- Sex
- Male
- Age
- 45 Years
- Healthy volunteers
- —
Summary
The goal of this observational study is to test whether the ExoDx Prostate test add value in biopsy decision making to patients with prostate cancer on an active surveillance regimen.
Detailed description
The current trial seeks to evaluate the role of the ExoDx Prostate test in men with low and favorable intermediate prostate cancer undergoing an active surveillance regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ExoDx Prostate | Observational only. |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
- First posted
- 2022-10-07
- Last updated
- 2022-10-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05572099. Inclusion in this directory is not an endorsement.